<DOC>
	<DOCNO>NCT01221337</DOCNO>
	<brief_summary>The adequate anti coagulation absolute necessity order avoid extra-corporal circuit haemodialyzer clot perform adequate renal replacement therapy haemodialysis session . In case multiple coagulation defect high haemorrhagic risk factor patient anti-coagulation therapy , recommend reduce heparin dos heparin free haemodialysis . Several strategy low heparin heparin free haemodialysis propose till , without real success . The heparin coat polyacrylonitrile haemodialyser ( EVODIAL ) report 90 % successful heparin-free haemodialysis session . On hand , vitamin E coat polysulphone ( VIE ) also report anti oxidative anti-thrombotic property capacity improve haemorrheological factor human blood , hence promising future perform successful haemodialysis session less without heparin . This randomised , multi-centric , cross-over open study design compare non inferiority haemodialyzer VIE 2,1 versus EVODIAL2,2 risk alfa 5 % absolute accept difference 12 % .</brief_summary>
	<brief_title>Heparin Free Haemodialysis With Haemodialyzers `` VIE '' Versus `` EVODIAL ''</brief_title>
	<detailed_description />
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Adult chronic haemodialysis patient since al least 3 month Two needle puncture fistula , Low molecular weight heparinization haemodialysis session , Good fistula central veinous catheter flow rate ( blood pump flow rate ≥ 300 ml/min ) , Systolic blood pressure ≥ 110 mmHg ( mean value three last dialysis session . Patients capable understand design study follow instruction Patients French social security system affiliation . Noninclusion criterion : C reactive protein &gt; 30 mg/L . Single needle puncture fistula Active document haemorrhage , Haemoglobin &lt; 10 g/dl and/or need blood transfusion , Documented thrombophilia Patients wait renal graft Acute sepsis Fistula catheter dysfunction Patients antivitamine K Per dialytic hypotension require al least nurse intervention , Severe diseases ( Dysglobulinemia , vascularitis , HIV… ) , Patients follow another research protocol end one less one month start study . Pregnant breast feeding patient , Minor patient lawprotection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>